The safety and efficacy of radium-223 dichloride for the treatment of advanced prostate cancer

E-session 398 / CME accredited Add to My Agenda

Expert:

Ettore Seregni, expert of session 'The safety and efficacy of radium-223 dichloride for the treatment of advanced prostate cancer'

Ettore Seregni, Head of Nuclear Medicine Therapy and Endocrinology
National Cancer Institute
Milan, Italy

Discussant: Niklaus Schaefer, Medical Oncologist and Nuclear Physician
University Hospital of Canton Vaud, Lausanne, Switzerland


The live session starts in about 5 days

Access to the live session is open 10 minutes before the start of the session



Share on:
Save to my calendar:

01
Jun 2017
18:15-19:00 CET

The live session starts in about 5 days